N‐alkyl‐substituted aryl‐piperazine drugs: Relationship between affinity for serotonin receptors and inhibition of aggression

N‐alkyl‐substituted aryl‐piperazine drugs: Relationship between affinity for serotonin... Buspirone is the first of several N‐alkyl‐substituted aryl‐piperazine‐containing drugs to be approved for use as an anxiolytic agent. These drugs do not interact with the benzodiazepine‐GABA receptor complex and therefore do not share the sedating and anticonvulsant effects of benzodiazepines. Buspirone and its analogs, gepirone and ipsapirone, act as agonists both pre‐ and postsynaptically at 5HTla receptor sites. A series of piperazine‐containing drugs was tested for their affinity at the 5HTla (postsynaptic) binding sites in hippocampus and compared with their ability to inhibit isolation‐induced aggression by mice. The potent 5HTla agonist, 8‐OH‐DPAT, was the most potent drug in both tests: IC50 = 1 nM, and ED50 = 2.4 μmol/kg for inhibition of (3H)‐5HT binding and aggression, respectively. There was a good correlation between ability to inhibit aggression and ability to inhibit (3H)‐5HT binding to hippocampal membranes. Fluprazine (DU 27716) was the major exception, but results with SKF 525‐A pretreatment to inhibit drug oxidation suggest that both fluprazine and metabolites have antiaggressive activity. Like other aryl‐piperazine drugs, fluprazine is potentiated by coadministration of a postsynaptic 5HT receptor antagonist, methysergide. Since antagonists of postsynaptic 5HT receptors potentiate gepirone and 8‐OH‐DPAT inhibition of aggression, these data suggest that affinity for 5HTla receptors at presynaptic autoreceptor sites is critical for the antiaggressive activity of these drugs and possibly for their anxiolytic effects. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Drug Development Research Wiley

N‐alkyl‐substituted aryl‐piperazine drugs: Relationship between affinity for serotonin receptors and inhibition of aggression

Loading next page...
 
/lp/wiley/n-alkyl-substituted-aryl-piperazine-drugs-relationship-between-eOhBGPetsC
Publisher
Wiley
Copyright
Copyright © 1988 Wiley‐Liss, Inc., A Wiley Company
ISSN
0272-4391
eISSN
1098-2299
DOI
10.1002/ddr.430120105
Publisher site
See Article on Publisher Site

Abstract

Buspirone is the first of several N‐alkyl‐substituted aryl‐piperazine‐containing drugs to be approved for use as an anxiolytic agent. These drugs do not interact with the benzodiazepine‐GABA receptor complex and therefore do not share the sedating and anticonvulsant effects of benzodiazepines. Buspirone and its analogs, gepirone and ipsapirone, act as agonists both pre‐ and postsynaptically at 5HTla receptor sites. A series of piperazine‐containing drugs was tested for their affinity at the 5HTla (postsynaptic) binding sites in hippocampus and compared with their ability to inhibit isolation‐induced aggression by mice. The potent 5HTla agonist, 8‐OH‐DPAT, was the most potent drug in both tests: IC50 = 1 nM, and ED50 = 2.4 μmol/kg for inhibition of (3H)‐5HT binding and aggression, respectively. There was a good correlation between ability to inhibit aggression and ability to inhibit (3H)‐5HT binding to hippocampal membranes. Fluprazine (DU 27716) was the major exception, but results with SKF 525‐A pretreatment to inhibit drug oxidation suggest that both fluprazine and metabolites have antiaggressive activity. Like other aryl‐piperazine drugs, fluprazine is potentiated by coadministration of a postsynaptic 5HT receptor antagonist, methysergide. Since antagonists of postsynaptic 5HT receptors potentiate gepirone and 8‐OH‐DPAT inhibition of aggression, these data suggest that affinity for 5HTla receptors at presynaptic autoreceptor sites is critical for the antiaggressive activity of these drugs and possibly for their anxiolytic effects.

Journal

Drug Development ResearchWiley

Published: Jan 1, 1988

Keywords: anxiolytics; buspirone; ipsapirone; 8‐OH‐DPAT

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off